[1] KUMAR H, KAWAI T, AKIRA S. Pathogen recognition in the innate immune response[J]. Biochemical Journal , 2009, 420(1):1-16. [2] LAMKANFI M, KANNEGANTI T D. Regulation of immune pathways by the NOD-like receptor NLRC 5[J]. Immunobiology , 2012, 217(1):13-16. [3] NEERINCX A, LAUTZ K, MENNING M, et al. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC 5 in antiviral responses[J]. Journal of Biological Chemistry , 2010, 285(34):26223-26232. [4] WILMANSK J M, PETNICKI-OCWIEJA T, KOBAYASHI K S. NLR proteins: integral 394 members of innate immunity and mediators of inflammatory diseases[J]. Journal of Leukocyte Biology , 2008, 83(1):13-30. [5] TING J P, LOVERING R C, ALNEMRI E S, et al, The NLR gene family: a standard nomenclature[J]. Immunity , 2008, 28(3):285-287. [6] CUI J, ZHU L, XIA X J, et al. NLRC5 negatively regulates the NF-kappa B and type I interferon signaling pathways[J]. Cell , 2010, 141(3):483-496. [7] DAVIS B K, ROBERTS R A, HUANG M T, et al. Cutting edge: NLRC 5-dependent activation of the inflammasome[J]. Journal of Immunobiology , 2011, 186(3):1333-1337. [8] LI HY, LIU H, WANG C H, et al. Deactivation of the kinase IKK by CUEDC2 though recruitment of the phosphatase PP1[J]. Nature Immunolbiology , 2008, 9(5):533-541. [9] BISWAS A, MEISSNER T B, KAWAI T, et al. Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator[J]. Journal of Immunolbiology , 2012, 189(2):516-520. [10] WANG L, LI K, XU Q, et al. Potential synergy between SNP and CpG-A or IL-1 beta in regulating transcriptional activity of IL-20 promoter[J]. Journal of Investigative Dermatology , 2014, 134(2):389-395. [11] KUENZEL S, TILL A, WINKLER M, et al. The nucleotide-binding oligomerization domain-like receptor NLRC 5 is involved in IFN-dependent antiviral immune responses[J]. Journal of Immunology , 2010, 184(4):1990-2000. [12] 常国斌,陈蓉,栾德琴,等. 细菌内毒素对鸡NLRC5受体及IFN基因转录的影响[J]. 畜牧兽医学报,2011,42(11):1598-1604. erinary Sciences , 2011, 42(11):1598-1604. (In Chinese with English abstract) [13] JENAL M, BRITSCHGI C, FEY M F, et al. Inactivation of the hypermethylated in cancer 1 tumour suppressor-not just a question of promoter hypermethylation[J]. Swiss Medical Weekly , 2010, 140:w13106. [14] DI MARCOTULLIO L, FERRETTI E, DE SMAELE E, et al. REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma[J]. Proceedings of the National Academy of Sciences of the United States of America , 2004, 101(29):10833-10838. [15] VALENTA T, LUKAS J, DOUBRAVSKA L, et al. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and β-catenin to the nuclear bodies[J]. The EMBO Journal , 2006, 25 (11):2326-2337. [16] ZHANG W,ZENG X, BRIGGS K J, et al. A potential tumor suppressor role for Hicl in breast cancer through transcriptional repression of ephrin-A1[J]. Oncogene , 2010, 29(17):2467-2476. [17] PAN S, WANG Z, CHEU Y, et al. Inactivation of tumor suppressor gene HIC1 in gastric cancer is reversed via small activating RNAs[J]. Gene , 2013, 527(1):102-108. [18] YANG Z H, ZHOU C L, ZHU H, et al. A functional SNP in the MDM2 promoter mediates E2F1 affinity to modulate cyclin D1 expression in tumor cell proliferation[J]. Asian Pacific Journal of Cancer Prevention , 2014, 15(8):3817-3823. [19] 彭云云. NLRC5靶向Wnt/β-catenin信号通路调控肝癌细胞增殖、迁移和侵袭的功能及机制研究[D]. 合肥:安徽医科大学,2015. PENG Y Y. Mechanisms of NLRC5 in the cell proliferation, migration and invasion of hepatocellular carcinoma by targeting the Wnt/ρ-catenin signaling pathway [D]. Hefei: Anhui Medical University, 2015. (in Chinese with English abstract) [20] TAMURA G, YIN J, WANG S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas[J]. Journal of the National Cancer Institute , 2000, 92(7):569-573. |